Hubble Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- March 25, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $7,300,000
Company Info
- Founders
- Jeff Sabados
- Company Description
- Hubble Therapeutics is a biotechnology research company that offers gene therapy for leber congenital amaurosis type 16.
- Market
- Gene Therapy for Retinal Diseases
- Location
- Hanover, NH, USA
- Coinvestors
- WARF Ventures